De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast
Clinical trial NCT07748260 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748260
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2031-07-01
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.